Pillstats
Rx only · Tablet · Oral

Methenamine Hippurate

Methenamine Hippurate

11 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US12 NDCs
11 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)6832
US makers12 labelers
Packages14
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 9 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.093$0.187$0.280$0.373Dec 2025Apr 2026Jul 2026
$0.312
Latest avg · Jul 22, 2026
-4%
Since Dec 17, 2025
11
Active US suppliers
31%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

11K22K33K44K2025 Q12025 Q22025 Q32025 Q42026 Q1
37K
Rx · 2026 Q1
2.3M
Units dispensed
+12%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it11 active · 1 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Micro Labs Limitedunknown2SUPPLYING
Jubilant Cadista Pharmaceuticals Inc.unknown2SUPPLYING
Aurobindo Pharma Limitedunknown1SUPPLYING
Golden State Medical Supply, Inc.unknown1SUPPLYING
Zydus Lifesciences Limitedunknown1SUPPLYING
AvPAKunknown1SUPPLYING
Ingenus Pharmaceuticals, LLCunknown1SUPPLYING
Viona Pharmaceuticals Incunknown1SUPPLYING
NorthStar Rx LLCunknown1SUPPLYING
Esjay Pharma LLCunknown1SUPPLYING
American Health Packagingunknown1SUPPLYING
Alvogen Inc.unknown1EXITED 2027

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.